Annual Total Liabilities
$7.69 M
+$4.60 M+148.63%
31 December 2023
Summary:
Virpax Pharmaceuticals annual total liabilities is currently $7.69 million, with the most recent change of +$4.60 million (+148.63%) on 31 December 2023. During the last 3 years, it has risen by +$5.61 million (+268.54%). VRPX annual total liabilities is now at all-time high.VRPX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.36 M
-$3.03 M-56.25%
30 September 2024
Summary:
Virpax Pharmaceuticals quarterly total liabilities is currently $2.36 million, with the most recent change of -$3.03 million (-56.25%) on 30 September 2024. Over the past year, it has dropped by -$5.34 million (-69.38%). VRPX quarterly total liabilities is now -69.38% below its all-time high of $7.69 million, reached on 31 December 2023.VRPX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRPX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -69.4% |
| 3 y3 years | +268.5% | +12.8% |
| 5 y5 years | +176.9% | -15.2% |
VRPX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +268.5% | -69.4% | +12.8% |
| 5 y | 5 years | at high | +268.5% | -69.4% | +30.0% |
| alltime | all time | at high | +513.5% | -69.4% | +30.0% |
Virpax Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.36 M(-56.3%) |
| June 2024 | - | $5.39 M(+24.0%) |
| Mar 2024 | - | $4.34 M(-43.5%) |
| Dec 2023 | $7.69 M(+148.6%) | $7.69 M(+17.8%) |
| Sept 2023 | - | $6.53 M(+79.1%) |
| June 2023 | - | $3.65 M(+10.7%) |
| Mar 2023 | - | $3.29 M(+6.4%) |
| Dec 2022 | $3.09 M | $3.09 M(-26.5%) |
| Sept 2022 | - | $4.21 M(+69.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $2.48 M(+13.6%) |
| Mar 2022 | - | $2.19 M(+4.8%) |
| Dec 2021 | $2.09 M(-55.4%) | $2.09 M(+15.2%) |
| Sept 2021 | - | $1.81 M(-53.0%) |
| June 2021 | - | $3.85 M(+5.2%) |
| Mar 2021 | - | $3.66 M(-21.8%) |
| Dec 2020 | $4.68 M(+68.5%) | $4.68 M(+8.9%) |
| Sept 2020 | - | $4.30 M(+54.6%) |
| Dec 2019 | $2.78 M(+121.6%) | $2.78 M |
| Dec 2018 | $1.25 M | - |
FAQ
- What is Virpax Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly total liabilities year-on-year change?
What is Virpax Pharmaceuticals annual total liabilities?
The current annual total liabilities of VRPX is $7.69 M
What is the all time high annual total liabilities for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual total liabilities is $7.69 M
What is Virpax Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of VRPX is $2.36 M
What is the all time high quarterly total liabilities for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly total liabilities is $7.69 M
What is Virpax Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, VRPX quarterly total liabilities has changed by -$5.34 M (-69.38%)